tirzepatide phase 3 trial 80 weeks weight change for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled The Next Frontier of Weight – surmount study tirzepatide after intensive
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



01443-4/asset/1245bc8d-99c6-4ac1-b69b-8c0220ceb8fd/main.assets/gr1.jpg)



















